Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Phase II Clinical Study of Thalidomide in the Treatment of Ankylosing Spondylitis

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT02201043
Recruitment Status : Completed
First Posted : July 25, 2014
Last Update Posted : November 20, 2015
Sponsor:
Information provided by (Responsible Party):
Shanghai Pharmaceuticals Holding Co., Ltd

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Completed
Actual Primary Completion Date : February 2015
Actual Study Completion Date : February 2015